A recent study found that 40 percent of the digital health funding in the first quarter of 2024 went to AI-enabled companies, up from 29 percent in 2022. Digital health companies remain attractive investments, in part due to their ability to avoid the steep labor costs and complex supply chains that plague other parts of the healthcare industry.
To read the entire story, you must be logged in.
Please log in now or register with us.
